{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T20:01:45Z","timestamp":1791489705595,"version":"4.3.4"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,8,28]],"date-time":"2020-08-28T00:00:00Z","timestamp":1598572800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,8,28]],"date-time":"2020-08-28T00:00:00Z","timestamp":1598572800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Research on Measures for Intractable Diseases, the Intractable Hepato-Biliary Diseases Study Group in Japan"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>The Japanese diagnostic guidelines for autoimmune hepatitis (AIH) were proposed in 2014. This study aimed to determine the trends and characteristics of AIH based on a Japanese nationwide survey. Data for 796 patients who were newly diagnosed with AIH from 2014 to 2017 were collected from January to March, 2019 from 54 hospitals throughout Japan. Clinical characteristics, including treatment, were compared with those reported in a prior 2015 survey. The population had a median age of 63\u00a0years at diagnosis, and the male to female ratio was 1:5.3. The numbers of women was significantly lower in this survey than in the 2015 survey. Moreover, the incidence of AIH with histological acute hepatitis increased significantly from 11.0 to 21.7%. The changes in the laboratory findings, such as in transaminase and immunoglobulin G levels and antinuclear antibody titers, as well as in prednisolone treatment, reflected an increasing incidence of acute AIH. The clinical characteristics of AIH changed rapidly, in parallel with the increasing incidence of acute AIH. The elucidation and diagnosis of AIH with acute hepatitis are important in the management of AIH.<\/jats:p>","DOI":"10.1038\/s41598-020-71296-0","type":"journal-article","created":{"date-parts":[[2020,8,28]],"date-time":"2020-08-28T10:09:48Z","timestamp":1598609388000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":31,"title":["Increasing incidence of acute autoimmune hepatitis: a nationwide survey in Japan"],"prefix":"10.1038","volume":"10","author":[{"given":"Atsushi","family":"Takahashi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiromasa","family":"Ohira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazumichi","family":"Abe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mikio","family":"Zeniya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masanori","family":"Abe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Teruko","family":"Arinaga-Hino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takuji","family":"Torimura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaname","family":"Yoshizawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akinobu","family":"Takaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jong-Hon","family":"Kang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshiyuki","family":"Suzuki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nobuhiro","family":"Nakamoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ayano","family":"Inui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Atsushi","family":"Tanaka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hajime","family":"Takikawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,8,28]]},"reference":[{"key":"71296_CR1","doi-asserted-by":"publisher","first-page":"1136","DOI":"10.1007\/s00535-011-0421-y","volume":"46","author":"M Abe","year":"2011","unstructured":"Abe, M. et al. Autoimmune hepatitis study group-subgroup of the intractable hepato-biliary disease study Group in Japan. Present status of autoimmune hepatitis in Japan: a nationwide survey. J. Gastroenterol. 46, 1136\u20131141 (2011).","journal-title":"J. Gastroenterol."},{"key":"71296_CR2","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1007\/s00535-016-1267-0","volume":"52","author":"A Takahashi","year":"2017","unstructured":"Takahashi, A. et al. Autoimmune hepatitis in Japan: trends in a nationwide survey. J. Gastroenterol. 52, 631\u2013640 (2017).","journal-title":"J. Gastroenterol."},{"key":"71296_CR3","doi-asserted-by":"publisher","first-page":"1079","DOI":"10.1007\/s00535-018-1444-4","volume":"53","author":"S Joshita","year":"2018","unstructured":"Joshita, S. et al. Clinical features of autoimmune hepatitis with acute presentation: a Japanese nationwide survey. J. Gastroenterol. 53, 1079\u20131088 (2018).","journal-title":"J. Gastroenterol."},{"key":"71296_CR4","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1007\/s12072-018-9848-z","volume":"12","author":"K Fujiwara","year":"2018","unstructured":"Fujiwara, K. et al. Long-term observation of acute-onset autoimmune hepatitis presenting clinically and radiologically as acute hepatitis. Hepatol. Int. 12, 191\u2013199 (2018).","journal-title":"Hepatol. Int."},{"key":"71296_CR5","doi-asserted-by":"publisher","first-page":"963","DOI":"10.1111\/hepr.12931","volume":"47","author":"K Harada","year":"2017","unstructured":"Harada, K., Hiep, N. C. & Ohira, H. Challenges and difficulties in pathological diagnosis of autoimmune hepatitis. Hepatol. Res. 47, 963\u2013971 (2017).","journal-title":"Hepatol. Res."},{"key":"71296_CR6","doi-asserted-by":"publisher","first-page":"961","DOI":"10.1136\/jclinpath-2016-204271","volume":"70","author":"H Nguyen Canh","year":"2017","unstructured":"Nguyen Canh, H. et al. Acute presentation of autoimmune hepatitis: a multicentre study with detailed histological evaluation in a large cohort of patients. J. Clin. Pathol. 70, 961\u2013969 (2017).","journal-title":"J. Clin. Pathol."},{"key":"71296_CR7","doi-asserted-by":"publisher","first-page":"1375","DOI":"10.1111\/hepr.12875","volume":"47","author":"K Dohmen","year":"2017","unstructured":"Dohmen, K., Tanaka, H., Haruno, M. & Aishima, S. Immunoserological and histological differences between autoimmune hepatitis with acute presentation and chronic autoimmune hepatitis. Hepatol. Res. 47, 1375\u20131382 (2017).","journal-title":"Hepatol. Res."},{"key":"71296_CR8","doi-asserted-by":"publisher","first-page":"1323","DOI":"10.2169\/internalmedicine.54.4125","volume":"54","author":"H Ohira","year":"2015","unstructured":"Ohira, H., Abe, K., Takahashi, A. & Watanabe, H. Autoimmune hepatitis: recent advances in the pathogenesis and new diagnostic guidelines in Japan. Intern. Med. 54, 1323\u20131328 (2015).","journal-title":"Intern. Med."},{"key":"71296_CR9","doi-asserted-by":"publisher","first-page":"630","DOI":"10.1111\/j.1872-034X.2012.01109.x","volume":"43","author":"K Yamamoto","year":"2013","unstructured":"Yamamoto, K. et al. Prognosis of autoimmune hepatitis showing acute presentation. Hepatol Res. 43, 630\u2013638 (2013).","journal-title":"Hepatol Res."},{"key":"71296_CR10","doi-asserted-by":"publisher","first-page":"262","DOI":"10.4254\/wjh.v4.i9.262","volume":"4","author":"K Abe","year":"2012","unstructured":"Abe, K. et al. Centrilobular necrosis in acute presentation of Japanese patients with type 1 autoimmune hepatitis. World J. Hepatol. 4, 262\u2013267 (2012).","journal-title":"World J. Hepatol."},{"key":"71296_CR11","doi-asserted-by":"crossref","unstructured":"Onji M. The Autoimmune Hepatitis Group. Proposal of autoimmune hepatitis presenting with acute hepatitis, severe hepatitis and acute liver failure. Hepatol Res. 41, 497 (2011).","DOI":"10.1111\/j.1872-034X.2011.00810.x"},{"key":"71296_CR12","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1002\/hep.24331","volume":"51","author":"K Fujiwara","year":"2011","unstructured":"Fujiwara, K., Yasui, S. & Yokosuka, O. Efforts for making the diagnosis of acute onset autoimmune hepatitis. Hepatology 51, 371\u2013372 (2011).","journal-title":"Hepatology"},{"key":"71296_CR13","doi-asserted-by":"publisher","first-page":"498","DOI":"10.1111\/j.1872-034X.2011.00808.x","volume":"41","author":"H Takahashi","year":"2011","unstructured":"Takahashi, H. & Zeniya, M. Acute presentation of autoimmune hepatitis: Does it exist? A published work review. Hepatol. Res. 41, 498\u2013504 (2011).","journal-title":"Hepatol. Res."},{"key":"71296_CR14","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/j.dld.2009.04.009","volume":"42","author":"Y Miyake","year":"2010","unstructured":"Miyake, Y. et al. Autoimmune hepatitis with acute presentation in Japan. Dig. Liver Dis. 42, 51\u201354 (2010).","journal-title":"Dig. Liver Dis."},{"key":"71296_CR15","doi-asserted-by":"publisher","first-page":"951","DOI":"10.1007\/s00535-008-2254-x","volume":"43","author":"K Fujiwara","year":"2008","unstructured":"Fujiwara, K., Fukuda, Y. & Yokosuka, O. Precise histological evaluation of liver biopsy specimen is indispensable for diagnosis and treatment of acute-onset autoimmune hepatitis. J. Gastroenterol. 43, 951\u2013958 (2008).","journal-title":"J. Gastroenterol."},{"key":"71296_CR16","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1016\/j.cgh.2006.10.011","volume":"5","author":"M Abe","year":"2007","unstructured":"Abe, M. et al. Clinicopathologic features of the severe form of acute type 1 autoimmune hepatitis. Clin. Gastroenterol. Hepatol. 5, 255\u2013258 (2007).","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"71296_CR17","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1016\/S1386-6346(02)00274-7","volume":"25","author":"N Okano","year":"2003","unstructured":"Okano, N. et al. Clinicopathological features of acute-onset autoimmune hepatitis. Hepatol. Res. 25, 263\u2013270 (2003).","journal-title":"Hepatol. Res."},{"key":"71296_CR18","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1016\/S1386-6346(01)00109-7","volume":"21","author":"M Abe","year":"2001","unstructured":"Abe, M. et al. Clinical characteristics of autoimmune hepatitis with histological features of acute hepatitis. Hepatol. Res. 21, 213\u2013219 (2001).","journal-title":"Hepatol. Res."},{"key":"71296_CR19","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1007\/BF02774713","volume":"20","author":"T Monna","year":"1985","unstructured":"Monna, T., Kuroki, T. & Yamamoto, S. Autoimmune hepatitis: the present status in Japan. Gastroenterol. Jpn. 20, 260\u2013272 (1985).","journal-title":"Gastroenterol. Jpn."},{"issue":"suppl 4","key":"71296_CR20","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1007\/BF02782906","volume":"28","author":"M Onji","year":"1993","unstructured":"Onji, M. et al. Present status of autoimmune hepatitis in Japan. Gastroenterol. Jpn. 28(suppl 4), 134\u2013138 (1993).","journal-title":"Gastroenterol. Jpn."},{"key":"71296_CR21","doi-asserted-by":"publisher","first-page":"1207","DOI":"10.1016\/S0168-8278(97)80453-9","volume":"26","author":"G Toda","year":"1997","unstructured":"Toda, G. et al. Present status of autoimmune hepatitis in Japan-correlating the characteristics with international criteria in an area with a high rate of HCV infection. J. Hepatol. 26, 1207\u20131212 (1997).","journal-title":"J. Hepatol."},{"key":"71296_CR22","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1111\/hepr.12300","volume":"44","author":"M Onji","year":"2014","unstructured":"Onji, M., Zeniya, M., Yamamoto, K. & Tsubouchi, H. Autoimmune hepatitis: Diagnosis and treatment guide in Japan, 2013. Hepatol. Res. 44, 368\u2013370 (2014).","journal-title":"Hepatol. Res."},{"key":"71296_CR23","volume-title":"JACR Monograph Supplement No 2","author":"K Katanoda","year":"2016","unstructured":"Katanoda, K. et al. JACR Monograph Supplement No 2 (Japanese Association of Cancer Registries, Tokyo, 2016)."},{"key":"71296_CR24","doi-asserted-by":"publisher","first-page":"881","DOI":"10.1111\/hepr.13342","volume":"49","author":"A Tanaka","year":"2009","unstructured":"Tanaka, A. et al. Increase trend in the prevalence and male-to-female ratio of primary biliary cholangitis, autoimmune hepatitis, and primary sclerosing cholangitis in Japan. Hepatol. Res. 49, 881\u2013889 (2009).","journal-title":"Hepatol. Res."},{"key":"71296_CR25","doi-asserted-by":"publisher","first-page":"971","DOI":"10.1016\/j.jhep.2015.06.030","volume":"63","author":"European Association for the Study of the Liver","year":"2015","unstructured":"European Association for the Study of the Liver. EASL clinical practice guidelines: autoimmune hepatitis. J. Hepatol. 63, 971\u20131004 (2015).","journal-title":"J. Hepatol."},{"key":"71296_CR26","doi-asserted-by":"publisher","first-page":"929","DOI":"10.1016\/S0168-8278(99)80297-9","volume":"31","author":"R Alzare","year":"1999","unstructured":"Alzare, R. et al. International Autoimmune Hepatitis Group Report: review of criteria for diagnosis of autoimmune hepatitis. J. Hepatol. 31, 929\u2013938 (1999).","journal-title":"J. Hepatol."},{"key":"71296_CR27","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1002\/hep.22322","volume":"48","author":"EM Hennes","year":"2008","unstructured":"Hennes, E. M. et al. Simplified criteria for the diagnosis of autoimmune hepatitis. Hepatology 48, 169\u2013176 (2008).","journal-title":"Hepatology"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-71296-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-71296-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-71296-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,6]],"date-time":"2022-12-06T18:24:51Z","timestamp":1670351091000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-71296-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,8,28]]},"references-count":27,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2020,12]]}},"alternative-id":["71296"],"URL":"https:\/\/doi.org\/10.1038\/s41598-020-71296-0","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,8,28]]},"assertion":[{"value":"23 January 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 August 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 August 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Atsushi Tanaka received fees for promotional materials from Novartis Pharma. The others declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"14250"}}